Mediaspace scheduled maintenance: Aug 25, 2026 07:00 - 12:00 AM. During this time, videos will be temporarily unavailable. Check status updates.

Recherche

Afficher tous les résultats pour

Accueil

Publication

Altered immune responses in mice without initial dermal lymphatics

Melody Swartz, Sachiko Hirosue
2009
Conference Papers

Source officielle

À propos
Confidentialité
Mentions légales

Graph Chatbot

Melody Swartz, Sachiko Hirosue
2009
Conference Papers

Source officielle

Publications associées (3)

https://infoscience.epfl.ch/entities/publication/b2d95632-e4ef-40c8-8a9f-4869a32c317f

À propos de ce résultat

Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.

Publications associées (3)

Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains

Jacques Fellay

Outbreaks of chilblains were reported during the COVID-19 pandemic. Given the essential role of type I interferon (I-IFN) in protective immunity against SARS-CoV-2 and the association of chilblains with inherited type I interferonopathies, we hypothesized ...

ROCKEFELLER UNIV PRESS2025

tRNA-derived fragments in T lymphocyte-beta cell crosstalk and in type 1 diabetes pathogenesis in NOD mice

Nicolas Jean Philippe Guex, Christian Iseli

Aims/hypothesistRNAs play a central role in protein synthesis. Besides this canonical function, they were recently found to generate non-coding RNA fragments (tRFs) regulating different cellular activities. The aim of this study was to assess the involveme ...

SPRINGER2024

An Immunomodulatory Gallotanin-Rich Fraction From Caesalpinia spinosa Enhances the Therapeutic Effect of Anti-PD-L1 in Melanoma

Amaia Martinez Usatorre

PD-1/PD-L1 pathway plays a role in inhibiting immune response. Therapeutic antibodies aimed at blocking the PD-1/PD-L1 interaction have entered clinical development and have been approved for a variety of cancers. However, the clinical benefits are reduced ...

FRONTIERS MEDIA SA2020